The past few years have seen major changes in our understanding of the PD disease process and its optimal management, with emergence of new therapies, potential biomarkers, strides in PD genetics, and a growing drive to test neuroprotective and diseasemodifying strategies. It is important that physicians dealing with individuals with PD are aware of these new data, and moreover, can assimilate them in a critical and productive fashion. We have therefore decided to focus upon presentations and discussions addressing the following specific needs:
1. How to improve short- and long- term disease course by incorporating recent advances in treatment into a logical and datadriven therapeutic strategy.
2. Given a growing emphasis on earlier treatment, how to improve accuracy and timeliness of diagnosis, and how enhanced recognition of motor and non motor symptoms of Parkinson’s disease may contribute to improved patient outcomes.
3. To gain familiarity with concepts of neuroprotection and disease modification, examining data from pre-clinical and clinical studies
Saturday, October 23, 2010 8:00 AM - 3:15 PM Eastern Time
Weill Cornell Medical College
1300 York Avenue (at 69th Street)
Second Floor Room C-200
New York, NY 10065
Full Day Conference Complimentary
Full Day Conference $25.00
Full Day Conference $100.00
8:00 AM: Course Agenda: Symposium Agenda
2:00 PM-3:15 PM: Workshop I: Botulinum toxin injections in the treatment of movement disorders: A case based approach
2:00 PM-3:15 PM: Workshop II: Video rounds: Unusual cases in Parkinson’s disease and other movement disorders
2:00 PM-3:15 PM Workshop III: Treating mood and cognition in movement disorders
RSVP online by Thursday, October 21, 2010; walk-ins accepted day of the symposium.
Please click here for more information or to register online.